Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSkinbiotherap. Regulatory News (SBTX)

Share Price Information for Skinbiotherap. (SBTX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.75
Bid: 12.50
Ask: 13.00
Change: 0.625 (5.15%)
Spread: 0.50 (4.00%)
Open: 12.25
High: 13.75
Low: 12.25
Prev. Close: 12.125
SBTX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

16 Mar 2021 10:50

RNS Number : 4221S
SkinBioTherapeutics PLC
16 March 2021
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

SkinBioTherapeutics plc

 

Company No: 09632164 (England)

 

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

x

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Seneca Partners Limited

City and country of registered office (if applicable)

Haydock, Greater Manchester UK

4. Full name of shareholder(s) (if different from 3.)v

Name

Share Nominees Limited, WCS Nominees Limited, Platform Securities Nominees Limited.

City and country of registered office (if applicable)

Aylesbury, Bucks, UK, London UK

5. Date on which the threshold was crossed or reachedvi:

12/03/2021

6. Date on which issuer notified (DD/MM/YYYY):

16/03/2021

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

10.4

10.4

155,889,922

Position of previous notification (if

applicable)

11.8

11.8

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary SharesGB00BF33H870

 16,255,710

 

N/A

10.4

N/A

SUBTOTAL 8. A

16,255,710

10.4

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

 

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

x

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

 

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

 

 

 

 

 

 

 

10. In case of proxy voting, please identify:

 

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

 

11. Additional informationxvi

 

 

 

 

Place of completion

Haydock, Greater Manchester UK

Date of completion

16 March 2021

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLJFMMTMTIBBLB
Date   Source Headline
22nd Mar 20247:00 amRNSHalf-year Report
18th Mar 202411:36 amRNSHolding(s) in Company
18th Mar 20247:00 amRNSNew research project and CSO to return to academia
12th Mar 20247:00 amRNSConversion Notice and Total Voting Rights
8th Mar 20249:43 amRNSNotice of Results
28th Feb 202412:41 pmRNSConversion notice and alternative financing
27th Feb 20247:00 amRNSPositive Interim AxisBiotix Acne study results
20th Feb 20247:00 amRNSDermatonics to launch Once Heel Balm in AMEA
9th Feb 20247:00 amRNSConversion Notice and Total Voting Rights
6th Feb 20247:31 amRNSDermatonics Full Year trading update
26th Jan 20247:00 amRNSCompletion of Acquisition of Dermatonics
25th Jan 20247:00 amRNSAcquisition of Dermatonics
25th Jan 20247:00 amRNS£5.0m Convertible Bond Facility & First Drawdown
29th Dec 202310:49 amRNSResult of AGM
29th Dec 20238:13 amRNSUpdate on transaction timelines to early 2024
6th Dec 20237:00 amRNSNotice of AGM and posting of Annual Report
30th Nov 20235:25 pmRNSFinal Results
30th Nov 20237:00 amRNSAxisBiotix-Psâ„¢ to launch on Amazon UK
24th Nov 20237:00 amRNSHolding(s) in Company
23rd Nov 20233:37 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSUpdate regarding Nominated Adviser and Broker
21st Nov 20237:00 amRNSResult of Retail Offer
17th Nov 20237:00 amRNSResult of Placing
16th Nov 20234:35 pmRNSRetail Offer
16th Nov 20234:33 pmRNSPlacing and Retail Offer
25th Oct 20237:25 amRNSAcne study, Trading and Auditor updates
19th Oct 20237:00 amRNSExtension of Croda contract for SkinBiotixâ„¢
15th Sep 20239:00 amRNShealth authority approval for AxisBiotix in France
5th Sep 20237:00 amRNSUpdate on acne programme
31st Jul 202312:51 pmRNSHolding(s) in Company
21st Jun 20237:00 amRNSRegulatory Approval
14th Jun 20234:46 pmRNSBusiness progress update
10th May 20237:00 amRNSSkinBiotix and AxisBiotix Update
14th Apr 20237:00 amRNSDirector/PDMR Shareholding
28th Mar 20231:45 pmRNSReplacement Half-year Report
28th Mar 20237:00 amRNSHalf-year Report
27th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20235:18 pmRNSDirector/PDMR Shareholding
9th Mar 20235:18 pmRNSDirector/PDMR Shareholding
7th Mar 20237:00 amRNSAxisBiotix-Ps™ approved for launch in Europe
20th Feb 202311:17 amRNSHolding(s) in Company
31st Jan 202311:15 amRNSResult of General Meeting
30th Jan 20234:28 pmRNSHolding(s) in Company
30th Jan 20239:00 amRNSHolding(s) in Company
16th Jan 20234:40 pmRNSSecond Price Monitoring Extn
16th Jan 20234:35 pmRNSPrice Monitoring Extension
6th Jan 20237:44 amRNSNotice of General Meeting - Replacement
6th Jan 20237:00 amRNSNotice of General Meeting
4th Jan 20231:33 pmRNSResult of General Meeting
30th Dec 202211:33 amRNSResults of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.